Hackensack is First Hospital in New Jersey to Use the Latest Innovation in Robotic Surgery
What you need to know
Hackensack is the first hospital in New Jersey to successfully perform surgeries using the da Vinci SP® Surgical System.
In June 2018, the U.S. Food and Drug Administration (FDA) cleared the da Vinci SP system for urologic surgical procedures that are appropriate for a single port approach.
Hackensack was one of only 10 sites in the U.S. selected to launch the new platform.
How Hackensack is Using the da Vinci SP Surgical System
The technology’s design enables single port surgery, narrow access surgery, triangulation and 360-degree rotation. To date the team has used the new technology to perform:
- Partial nephrectomy
- Radical nephrectomy
- Radical prostatectomy
- Pyeloplasty
- Ureteroplasty
- Ureteroplasty with mucosal graft
The FDA recently cleared the da Vinci SP for radical tonsillectomy and tongue base resection, and Hackensack’s otolaryngology (ENT) specialists will begin using the single port technology by summer 2019.
Hackensack anticipates additional submissions for FDA approval in a number of specialties, including colorectal surgery. When approved, the colorectal team expects to begin using the new platform.